Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ANTIPSYCHOTIC' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1771 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Berlind, A
      Effects of haloperidol and phentolamine on the crustacean cardiac ganglion

      COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY
    2. Berlind, A
      Monoamine pharmacology of the lobster cardiac ganglion

      COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY
    3. Ellis, KA; Nathan, PJ
      The pharmacology of human working memory

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    4. Ghaemi, SN
      On defining 'mood stabilizer'

      BIPOLAR DISORDERS
    5. Bao, JQ; Potts, BD
      Quantitative determination of olanzapine in rat brain tissue by high-performance liquid chromatography with electrochemical detection

      JOURNAL OF CHROMATOGRAPHY B
    6. Raggi, MA; Casamenti, G; Mandrioli, R; Volterra, V
      A sensitive high-performance liquid chromatographic method using electrochemical detection for the analysis of olanzapine and desmethylolanzapine in plasma of schizophrenic patients using a new solid-phase extraction procedure

      JOURNAL OF CHROMATOGRAPHY B
    7. Agelink, MW; Zeit, T; Baumann, B; Majewski, T; Lemmer, W; Postert, T; Lukas, K; Klieser, E
      In vivo cardiovascular effects of the new atypical neuroleptic sertindole

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    8. Devoto, P; Flore, G; Pani, L; Gessa, G
      Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex

      MOLECULAR PSYCHIATRY
    9. Rothermundt, M; Missler, U; Arolt, V; Peters, M; Leadbeater, J; Wiesmann, M; Rudolf, S; Wandinger, KP; Kirchner, H
      Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology

      MOLECULAR PSYCHIATRY
    10. Mirnics, K; Middleton, FA; Stanwood, GD; Lewis, DA; Levitt, P
      Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia

      MOLECULAR PSYCHIATRY
    11. Ohtsuki, T; Sakurai, K; Dou, H; Toru, M; Yamakawa-Kobayashi, K; Arinami, T
      Mutation analysis of the NMDAR2B (GRIN2B) gene in schizophrenia

      MOLECULAR PSYCHIATRY
    12. Bowden, CL
      Novel treatments for bipolar disorder

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    13. Hirose, S
      Restlessness in suboccipital muscles as a manifestation of akathisia

      PSYCHIATRY AND CLINICAL NEUROSCIENCES
    14. Ananth, J; Burgoyne, KS; Gadasalli, R; Aquino, S
      How do the atypical antipsychotics work?

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    15. Diaz, E; Levine, HB; Sullivan, MC; Sernyak, MJ; Hawkins, KA; Cramer, JA; Woods, SW
      Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    16. Depatie, L; Lal, S
      Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    17. Tempier, R; Pawliuk, N
      Influence of novel and conventional antipsychotic medication on subjectivequality of life

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    18. Purdon, SE; Malla, A; Labelle, A; Lit, W
      Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    19. Khullar, A; Chue, P; Tibbo, P
      Quetiapine and obsessive-compulsive symptoms (OCS): case report and reviewof atypical antipsychotic-induced OCS

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    20. Arranz, MJ; Mancama, D; Kerwin, RW
      Neurotransmitter receptor variants and their influence on antipsychotic treatment (Review)

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    21. Ball, MP; Coons, VB; Buchanan, RW
      A program for treating olanzapine-related weight gain

      PSYCHIATRIC SERVICES
    22. Osser, DN; Sigadel, R
      Short-term inpatient pharmacotherapy of schizophrenia

      HARVARD REVIEW OF PSYCHIATRY
    23. Bonanno, DG; Davydov, L; Botts, SR
      Olanzapine-induced diabetes mellitus

      ANNALS OF PHARMACOTHERAPY
    24. Farver, DK; Khan, MH
      Zolpidem for antipsychatic-induced parkinsonism

      ANNALS OF PHARMACOTHERAPY
    25. Carrick, R; Mitchell, A; Lloyd, K
      User involvement in research: Power and compromise

      JOURNAL OF COMMUNITY & APPLIED SOCIAL PSYCHOLOGY
    26. Harrison, PJ; Eastwood, SL
      Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia

      HIPPOCAMPUS
    27. Dose, M; Hahlweg, K
      Medicinal and psychological treatment of schizophrenia

      VERHALTENSTHERAPIE
    28. Huang, YS; Luedtke, RR; Freeman, RA; Wu, L; Mach, RH
      Synthesis of 2-(2,3-dimethoxyphenyl)-4-(aminomethyl)imidazole analogues and their binding affinities for dopamine D-2 and D-3 receptors

      BIOORGANIC & MEDICINAL CHEMISTRY
    29. Beelen, AP; Yeo, KTJ; Lewis, LD
      Asymptomatic QTc prolongation associated with quetiapine fumarate overdosein a patient being treated with risperidone

      HUMAN & EXPERIMENTAL TOXICOLOGY
    30. Lyons, D; McLoughlin, DM
      Recent advances - Psychiatry

      BRITISH MEDICAL JOURNAL
    31. Monroy, X; Romero, G; Perez, MP; Farre, AJ; Guitart, X
      Decrease of adenylyl cyclase activity and expression by a sigma(1) receptor ligand and putative atypical antipsychotic

      NEUROREPORT
    32. See, RE; Berglind, WJ
      Decreased pallidal GABA following reverse microdialysis with, clozapine, but not haloperidol

      NEUROREPORT
    33. Goudie, AJ; Baker, LE; Smith, JA; Prus, AJ; Svensson, KA; Cortes-Burgos, LA; Wong, EHF; Haadsma-Svensson, S
      Common discriminative stimulus properties in rats of muscarinic antagonists, clozapine and the D-3 preferring antagonist PNU-99194A: an analysis of possible mechanisms

      BEHAVIOURAL PHARMACOLOGY
    34. Lucas, G; Di Matteo, V; De Deurwaerdere, P; Porras, G; Martin-Ruiz, R; Artigas, F; Esposito, E; Spampinato, U
      Neurochemical and electrophysiological evidence that 5-HT4 receptors exerta state-dependent facilitatory control in vivo on nigrostriatal, but not mesoaccumbal, dopaminergic function

      EUROPEAN JOURNAL OF NEUROSCIENCE
    35. Legault, M; Wise, RA
      Novelty-evoked elevations of nucleus accumbens dopamine: dependence on impulse flow from the ventral subiculum and glutamatergic neurotransmission inthe ventral tegmental area

      EUROPEAN JOURNAL OF NEUROSCIENCE
    36. Rolland, A; Fleurentin, J; Lanhers, MC; Misslin, R; Mortier, F
      Neurophysiological effects of an extract of Eschscholzia californica cham.(Papaveraceae)

      PHYTOTHERAPY RESEARCH
    37. Rijcken, CAW; Dekens-Konter, JAM; Knegtering, H; de Jong-van den Berg, LTW
      Reporting sexual function disorders caused by antipsychotic drugs: is there a role for the community pharmacy?

      PHARMACY WORLD & SCIENCE
    38. Bustillo, JR; Lauriello, J; Rowland, LM; Jung, RE; Petropoulos, H; Hart, BL; Blanchard, J; Keith, SJ; Brooks, WM
      Effects of chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophrenia

      PSYCHIATRY RESEARCH-NEUROIMAGING
    39. Bernardo, M; Parellada, E; Lomena, F; Catafau, AM; Font, M; Gomez, JC; Lopez-Carrero, C; Gutierrez, F; Pavia, J; Salamero, M
      Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint [I-123]IBZM SPECT study

      PSYCHIATRY RESEARCH-NEUROIMAGING
    40. Melkersson, K; Khan, A; Hilding, A; Hulting, AL
      Different effects of antipsychotic drugs on insulin release in vitro

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    41. Gefvert, O; Lundberg, T; Wieselgren, IM; Bergstrom, M; Langstrom, B; Wiesel, FA; Lindstrom, L
      D-2 and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    42. Floris, M; Lejeune, J; Deberdt, W
      Effect of amantadine on weight gain during olanzapine treatment

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    43. Sharma, T
      Quetiapine - efficacy in different domains

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    44. Kasper, S; Tauscher, J; Heiden, A
      Quetiapine: efficacy and tolerability in schizophrenia

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    45. Lynch, J; Morrison, J; Graves, N; Meddis, D; Drummond, MF; Hellewell, JSE
      The health economic implications of treatment with quetiapine: an audit oflong-term treatment for patients with chronic schizophrenia

      EUROPEAN PSYCHIATRY
    46. Salzman, C
      Treatment of the agitation of late-life psychosis and Alzheimer's disease

      EUROPEAN PSYCHIATRY
    47. Scatton, B; Cohen, C; Perrault, G; Oblin, A; Claustre, Y; Schoemaker, H; Sanger, DJ; Rouquier, L; Porsolt, R
      The preclinical pharmacologic profile of tiapride

      EUROPEAN PSYCHIATRY
    48. Cornblatt, BA; Lencz, T; Kane, JM
      Treatment of the schizophrenia prodrome: is it presently ethical?

      SCHIZOPHRENIA RESEARCH
    49. McGlashan, TH
      Psychosis treatment prior to psychosis onset: ethical issues

      SCHIZOPHRENIA RESEARCH
    50. Naber, D; Moritz, S; Lambert, M; Rajonk, F; Holzbach, R; Mass, R; Andresen, B; Frank, P; Rudiger, H; Reinhard, M; Burghard, A
      Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs

      SCHIZOPHRENIA RESEARCH
    51. Ganguli, R; Brar, JS; Ayrton, Z
      Weight gain over 4 months in schizophrenia patients: a comparison of olanzapine and risperidone

      SCHIZOPHRENIA RESEARCH
    52. Konicki, PE; Kwon, KY; Steele, V; White, J; Fuller, M; Jurjus, GJ; Jaskiw, GE
      Prefrontal cortical sulcal widening associated with poor treatment response to clozapine

      SCHIZOPHRENIA RESEARCH
    53. Taiminen, T; Huttunen, J; Heila, H; Henriksson, M; Isometsa, E; Kahkonen, J; Tuominen, K; Lonnqvist, J; Addington, D; Helenius, H
      The Schizophrenia Suicide Risk Scale (SSRS): development and initial validation

      SCHIZOPHRENIA RESEARCH
    54. Martin, BC; Miller, LS; Kotzan, JA
      Antipsychotic prescription use and costs for persons with schizophrenia inthe 1990s: current trends and five year time series forecasts

      SCHIZOPHRENIA RESEARCH
    55. Theodoropoulou, S; Spanakos, G; Baxevanis, CN; Economou, M; Gritzapis, AD; Papamichail, MP; Stefanis, CN
      Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients

      SCHIZOPHRENIA RESEARCH
    56. Lavalaye, J; Linszen, DH; Booij, J; Dingemans, PMAJ; Reneman, L; Habraken, BAJ; Gersons, BPR; van Royen, EA
      Dopamine transporter density in young patients with schizophrenia assessedwith [(123)] FP-CIT SPECT

      SCHIZOPHRENIA RESEARCH
    57. Martin, J; Jeste, DV; Caliguiri, MP; Patterson, T; Heaton, R; Ancoli-Israel, S
      Actigraphic estimates of circadian rhythms and sleep/wake in older schizophrenia patients

      SCHIZOPHRENIA RESEARCH
    58. Gjere, NA
      Psychopharmacology in pregnancy

      JOURNAL OF PERINATAL & NEONATAL NURSING
    59. Voruganti, L; Slomka, P; Zabel, P; Costa, G; So, A; Mattar, A; Awad, AG
      Subjective effects of AMPT-induced dopamine depletion in schizophrenia: Correlation between dysphoric responses and striatal D-2 binding ratios on SPECT imaging

      NEUROPSYCHOPHARMACOLOGY
    60. Scheepers, FE; Wied, CCG; Westenberg, HGM; Kahn, RS
      The effect of olanzapine treatment on monoamine metabolite concentrations in the cerebrospinal fluid of schizophrenic patients

      NEUROPSYCHOPHARMACOLOGY
    61. Mukherjee, J; Christian, BT; Narayanan, TK; Shi, BH; Mantil, J
      Evaluation of, dopamine D-2 receptor occupancy by clozapine, risperidone, and haloperidol in vivo in the rodent and nonhuman primate brain using F-18-fallypride

      NEUROPSYCHOPHARMACOLOGY
    62. Barbaccia, ML; Affricano, D; Purdy, RH; Maciocco, E; Spiga, F; Biggio, G
      Clozapine, but not haloperidol, increases brain concentrations of neuroactive steroids in the rat

      NEUROPSYCHOPHARMACOLOGY
    63. Hemsley, KM; Crocker, AD
      Changes in muscle tone are regulated by D1 and D2 dopamine receptors in the ventral striatum and D1 receptors in the substantia nigra

      NEUROPSYCHOPHARMACOLOGY
    64. Ouagazzal, AM; Grottick, AJ; Moreau, JL; Higgins, GA
      Effect of LSD on prepulse inhibition and spontaneous behavior in the rat: A pharmacological analysis and comparison between two rat strains

      NEUROPSYCHOPHARMACOLOGY
    65. Audinot, V; Newman-Tancredi, A; Cussac, D; Millan, MJ
      Inverse agonist properties of antipsychotic agents at cloned, human (h) serotonin (5-HT)(1B) and h5-HT1D receptors

      NEUROPSYCHOPHARMACOLOGY
    66. Moy, SS; Knapp, DJ; Breese, GR
      Effect of olanzapine on functional responses from sensitized D-1-dopamine receptors in rats with neonatal dopamine loss

      NEUROPSYCHOPHARMACOLOGY
    67. Stine, CD; Lu, WX; Wolf, ME
      Expression of AMPA receptor flip and flop mRNAs in the nucleus accumbens and prefrontal cortex after neonatal ventral hippocampal lesions

      NEUROPSYCHOPHARMACOLOGY
    68. Meltzer, H; Lee, MA; Jayathilake, K
      The blunted plasma cortisol response to apomorphine and its relationship to treatment response in patients with schizophrenia

      NEUROPSYCHOPHARMACOLOGY
    69. Jardemark, KE; Ai, JL; Ninan, I; Wang, RY
      Biphasic modulation of NMDA-induced responses in pyramidal cells of the medial prefrontal cortex by Y-931, a potential atypical antipsychotic drug

      SYNAPSE
    70. Bubser, M; Backstrom, JR; Sanders-Bush, E; Roth, BL; Deutch, AY
      Distribution of serotonin 5-HT2A receptors in afferents of the rat striatum

      SYNAPSE
    71. Rodriguez, JJ; Garcia, DR; Nakabeppu, Y; Pickel, VM
      FosB in rat striatum: Normal regional distribution and enhanced expressionafter 6-month haloperidol administration

      SYNAPSE
    72. Sakai, K; Gao, XM; Hashimoto, T; Tamminga, CA
      Traditional and new antipsychotic drugs differentially alter neurotransmission markers in basal ganglia-thalamocortical neural pathways

      SYNAPSE
    73. Roberts, RC
      Effect of chronic olanzapine treatment on striatal synaptic organization

      SYNAPSE
    74. Gemesi, LI; Kapas, M; Szeberenyi, S
      Application of LC-MS analysis to the characterisation of the in vitro and in vivo metabolite profiles of RGH-1756 in the rat

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    75. Schanda, H
      Mental health care at the turn of the millennium - On the way towards two-class psychiatry?

      FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
    76. Schmitt, A; Weber-Fahr, W; Jatzko, A; Tost, H; Henn, FA; Braus, DF
      Structural magnetic resonance imaging in schizophrenia: An overview

      FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
    77. Rao, ML; Hiemke, C; Grasmader, K; Baumann, P
      Olanzapine: Pharmacology, pharmacokinetics and therapeutic drug monitoring

      FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
    78. Pollmacher, T; Schuld, A; Kraus, T; Haack, M; Hinze-Selch, D
      On the clinical relevance of clozapine-triggered release of cytokines and soluble cytokine-receptors

      FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
    79. Baptista, T; Lacruz, A; Meza, T; Contreras, Q; Delgado, C; Mejias, MA; Hernandez, L
      Antipsychotic drugs and obesity: Is prolactin involved?

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    80. Herbener, ES; Harrow, M
      Longitudinal assessment of negative symptoms in schizophrenia/schizoaffective patients, other psychotic patients, and depressed patients

      SCHIZOPHRENIA BULLETIN
    81. Kim, KE; Cho, WJ; Chang, SJ; Yong, CS; Lee, CH; Kim, DD
      Pharmacokinetics of a new antitumor 3-arylisoquinoline derivative, CWJ-a-5

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    82. Vinod, KY; Subhash, MN; Srinivas, BN
      Differential protection and recovery of 5-HT1A receptors from N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) inactivation in regions of rat brain

      NEUROCHEMICAL RESEARCH
    83. Cohen, H; Loewenthal, U; Matar, MA; Kotler, M
      Reversal of pathologic cardiac parameters after transition from clozapine to olanzapine treatment: A case report

      CLINICAL NEUROPHARMACOLOGY
    84. Koskinen, T; Sirvio, J
      Studies on the involvement of the dopaminergic system in the 5-HT2 agonist(DOI)-induced premature responding in a five-choice serial reaction time task

      BRAIN RESEARCH BULLETIN
    85. Ashcroft, R; Fraser, B; Kerr, M; Ahmed, Z
      Are antipsychotic drugs the right treatment for challenging behaviour in learning disability?: The place of a randomised trial

      JOURNAL OF MEDICAL ETHICS
    86. Melkersson, KI; Hulting, AL; Rane, AJ
      Dose requirement and prolactin elevation of antipsychotics in male and female patients with schizophrenia or related psychoses

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    87. de Visser, SJ; van der Post, J; Pieters, MSM; Cohen, AF; van Gerven, JMA
      Biomarkers for the effects of antipsychotic drugs in healthy volunteers

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    88. Esel, E; Basturk, M; Gonul, AS; Kula, M; Turan, MT; Yabanoglu, I; Sofuoglu, S
      Effects of olanzapine and haloperidol on serum prolactin levels in male schizophrenic patients

      PSYCHONEUROENDOCRINOLOGY
    89. Marek, GJ; Wright, RA; Gewirtz, JC; Schoepp, DD
      A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex

      NEUROSCIENCE
    90. Stutzmann, GE; Marek, GJ; Aghajanian, GK
      Adenosine preferentially suppresses serotonin(2a) receptor-enhanced excitatory postsynaptic currents in layer V neurons of the rat medial prefrontal cortex

      NEUROSCIENCE
    91. Eastwood, SL; Cotter, D; Harrison, PJ
      Cerebellar synaptic protein expression in schizophrenia

      NEUROSCIENCE
    92. Nudmamud, S; Reynolds, GP
      Increased density of glutamate/N-methyl-D-aspartate receptors in superior temporal cortex in schizophrenia

      NEUROSCIENCE LETTERS
    93. Fadel, J; Dobner, PR; Deutch, AY
      The neurotensin antagonist SR 48692 attenuates haloperidol-induced striatal Fos expression in the rat

      NEUROSCIENCE LETTERS
    94. Kim, YB; Jang, J; Chung, YM; Baeg, EH; Kim, HT; Mook-Jung, I; Kim, SU; Jung, MW; Chung, YK
      Haloperidol and clozapine increase neural activity in the rat prefrontal cortex

      NEUROSCIENCE LETTERS
    95. Yoshimura, R; Ueda, N; Nakamura, J
      Possible relationship between combined plasma concentrations of risperidone plus 9-hydroxyrisperidone and extrapyramidal symptoms - Preliminary study

      NEUROPSYCHOBIOLOGY
    96. Schmitt, A; Maras, A; Petroianu, G; Braus, DF; Scheuer, L; Gattaz, WF
      Effects of antipsychotic treatment on membrane phospholipid metabolism in schizophrenia

      JOURNAL OF NEURAL TRANSMISSION
    97. Yoon, HY; Hwang, SH; Lee, EY; Kim, TU; Cho, EH; Cho, SW
      Effects of ADP on different inhibitory properties of brain glutamate dehydrogenase isoproteins by perphenazine.

      BIOCHIMIE
    98. Niizato, K; Genda, K; Nakamura, R; Iritani, S; Ikeda, K
      Cognitive decline in schizophrenics with Alzheimer's disease: A mini-review of neuropsychological and neuropathological studies

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    99. Crocker, AD; Hemsley, KM
      An animal model of extrapyramidal side effects induced by antipsychotic drugs: Relationship with D2 dopamine receptor occupancy

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    100. Sethi, KD
      Movement disorders induced by dopamine blocking agents

      SEMINARS IN NEUROLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/06/20 alle ore 11:30:12